CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors
Latest Information Update: 06 Dec 2022
At a glance
- Drugs TAA6 chimeric antigen receptor T cell therapy PersonGen BioTherapeutics (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors PersonGen Biotherapeutics
- 05 Jan 2021 New trial record